CY1113865T1 - Ταχεια elisa - Google Patents

Ταχεια elisa

Info

Publication number
CY1113865T1
CY1113865T1 CY20131100266T CY131100266T CY1113865T1 CY 1113865 T1 CY1113865 T1 CY 1113865T1 CY 20131100266 T CY20131100266 T CY 20131100266T CY 131100266 T CY131100266 T CY 131100266T CY 1113865 T1 CY1113865 T1 CY 1113865T1
Authority
CY
Cyprus
Prior art keywords
elisa
speed
mixing
binding partner
homogeneous phase
Prior art date
Application number
CY20131100266T
Other languages
English (en)
Inventor
Duccio Berti
Daniele Casini
Paola Fontani
Original Assignee
Novartis Vaccines And Diagnostics S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0522600A external-priority patent/GB0522600D0/en
Priority claimed from GB0602336A external-priority patent/GB0602336D0/en
Application filed by Novartis Vaccines And Diagnostics S.R.L. filed Critical Novartis Vaccines And Diagnostics S.R.L.
Publication of CY1113865T1 publication Critical patent/CY1113865T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Ένα στάδιο στην ενζυμική ανοσοπροσροφητική δοκιμασία (ELISA) μεταβάλλεται από ετερογενή φάση σε ομογενή φάση, για να παράσχει πολύ βραχύτερο συνολικό χρόνο ολοκληρώσεως. Η νέα δοκιμασία περιλαμβάνει τα στάδια (i) της αναμίξεως σε μία ομογενή φάση ενός δείγματος και ενός πρώτου εταίρου δεσμεύσεως της προσδιοριζόμενης ουσίας για το σχηματισμό ενός πρώτου προϊόντος αναμίξεως· και (ii) της εκθέσεως του πρώτου προϊόντος αναμίξεως σε ένα δεύτερο εταίρο δεσμεύσεως της προσδιοριζόμενης ουσίας.
CY20131100266T 2005-11-04 2013-03-29 Ταχεια elisa CY1113865T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0522600A GB0522600D0 (en) 2005-11-04 2005-11-04 Rapid elisa
GB0602336A GB0602336D0 (en) 2006-02-06 2006-02-06 Rapid elisa
EP06847258A EP1952151B1 (en) 2005-11-04 2006-11-03 Rapid elisa

Publications (1)

Publication Number Publication Date
CY1113865T1 true CY1113865T1 (el) 2016-07-27

Family

ID=38123269

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100266T CY1113865T1 (el) 2005-11-04 2013-03-29 Ταχεια elisa

Country Status (9)

Country Link
US (1) US20100035285A1 (el)
EP (2) EP2392924A1 (el)
CY (1) CY1113865T1 (el)
DK (1) DK1952151T3 (el)
ES (1) ES2399350T3 (el)
PL (1) PL1952151T3 (el)
PT (1) PT1952151E (el)
SI (1) SI1952151T1 (el)
WO (1) WO2007066231A2 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2858794A1 (en) 2011-12-12 2013-06-20 Novartis Ag Assays for influenza virus hemagglutinins
US10598666B2 (en) 2012-03-08 2020-03-24 Glaxosmithkline Biologicals Sa In vitro potency assay for protein-based meningococcal vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9705376D0 (en) * 1997-03-14 1997-04-30 Harris William J Antibody fragment formulations and assay formats for detecting the presence an d concentration of analytes
US6689566B1 (en) * 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
US7393647B2 (en) * 2003-05-27 2008-07-01 Biosite Incorporated Methods for detecting B. anthracis infection

Also Published As

Publication number Publication date
EP2392924A1 (en) 2011-12-07
EP1952151B1 (en) 2013-01-02
ES2399350T3 (es) 2013-03-27
SI1952151T1 (sl) 2013-03-29
WO2007066231A3 (en) 2007-10-18
WO2007066231A2 (en) 2007-06-14
EP1952151A2 (en) 2008-08-06
PT1952151E (pt) 2013-02-14
PL1952151T3 (pl) 2013-05-31
US20100035285A1 (en) 2010-02-11
DK1952151T3 (da) 2013-04-08

Similar Documents

Publication Publication Date Title
NO2017032I1 (no) bezlotoksumab
BRPI0316384B8 (pt) imunoensaio não competitivo para analitos pequenos
CR10612A (es) Anticuerpo especifico prlr y sus usos
EA200601545A1 (ru) АНТИ-Aβ АНТИТЕЛА
DE602005010579D1 (de) Nachweis von arzneistoffen der methamphetamingruppe
DE60232688D1 (de) Grenzflächen-biomaterialien
FR14C0064I2 (fr) Anticorps anti-il-6, compositions, methodes et utilisations associees
CL2012003245A1 (es) Proteína de unión a antígeno aislada que se une a linfopoyetina estromal tímica (tslp); composición que comprende una proteína de unión a antígeno que une tslp correspondiente a un anticuerpo humano anti-tslp.
DK1851250T3 (da) Humant monoklonalt antistof mod prostataspecifikt membranantigen (psma)
TR201901841T4 (tr) Her antikorlarının sabit dozlaması.
NO20076003L (no) TGF-beta 1 spesifikke antistoffer
ATE445386T1 (de) Polymerische parfümpartikel
WO2004041061A8 (en) Substrates, devices, and methods for cellular assays
BR0214621A (pt) Moléculas de automontagem
ATE449337T1 (de) Assay
DK2171060T3 (da) Superagonistisk anti-CD28-antistof
NO20063240L (no) Byggematerialer av gips som har oket termisk ledningsevne og svekket avskjerming
DK1492869T3 (da) Transplantataccept-inducerende celler af monocytisk oprindelse, deres fremstilling og anvendelse
EA200702193A1 (ru) Гликозилирование белков
NO20051715L (no) HCV assay
BRPI0510561A (pt) epìtopos que induzem morte de célula t
CY1113865T1 (el) Ταχεια elisa
ATE467128T1 (de) Kolloidale metallkonjugate
ATE405837T1 (de) Festphase immunochromatographische testverfahren
WO2006020263A3 (en) Cytoxan antibodies and immunoassay